Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel urea linked ciprofloxacin-chalcone hybrids having antiproliferative topoisomerases I/II inhibitory activities and caspases-mediated apoptosis
Hamada H. H. Mohammed, Samar H. Abbas, Alaa M. Hayallah, et al.
Bioorganic Chemistry (2020) Vol. 106, pp. 104422-104422
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

New 1,2,3-triazole linked ciprofloxacin-chalcones induce DNA damage by inhibiting human topoisomerase I& II and tubulin polymerization
Hamada H. H. Mohammed, Amer Ali Abd El‐Hafeez, Kareem Ebeid, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1346-1363
Open Access | Times Cited: 37
Topoisomerase II inhibitors design: Early studies and new perspectives
Hadeer K. Swedan, Asmaa E. Kassab, Ehab M. Gedawy, et al.
Bioorganic Chemistry (2023) Vol. 136, pp. 106548-106548
Closed Access | Times Cited: 25
Chalcones and Gastrointestinal Cancers: Experimental Evidence
Radka Michalková, Martin Kello, Martina Čižmáriková, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5964-5964
Open Access | Times Cited: 17
Indole Derivatives: A Versatile Scaffold in Modern Drug Discovery—An Updated Review on Their Multifaceted Therapeutic Applications (2020–2024)
Xingyou Mo, Devendra Pratap Rao, Kirandeep Kaur, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4770-4770
Open Access | Times Cited: 6
Synthesis of New Thiazole-Privileged Chalcones as Tubulin Polymerization Inhibitors with Potential Anticancer Activities
Hamada Hashem, Abdelfattah Hassan, Walid M. Abdelmagid, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 9, pp. 1154-1154
Open Access | Times Cited: 5
From Infection to Tumor: Exploring the Therapeutic Potential of Ciprofloxacin Derivatives as Anticancer Agents
Hesham M. Hassan, Roket Hassan, Ranya Mohammed Elmagzoub, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 72-72
Open Access
N-Acylated Ciprofloxacin Derivatives: Synthesis and In Vitro Biological Evaluation as Antibacterial and Anticancer Agents
Marta Struga, Piotr Roszkowski, Anna Bielenica, et al.
ACS Omega (2023) Vol. 8, Iss. 21, pp. 18663-18684
Open Access | Times Cited: 14
Synthesis, Physicochemical Characterization using a Facile Validated HPLC Quantitation Analysis Method of 4-Chloro-phenylcarbamoyl-methyl Ciprofloxacin and Its Biological Investigations
Mostafa F. Al-Hakkani, Nourhan Ahmed, Alaa A. Abbas, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14818-14818
Open Access | Times Cited: 14
Recent Development of Fluoroquinolone Derivatives as Anticancer Agents
Justyna Nowakowska, Dominika Radomska, Robert Czarnomysy, et al.
Molecules (2024) Vol. 29, Iss. 15, pp. 3538-3538
Open Access | Times Cited: 4
Unveiling the Anticancer Potential of a New Ciprofloxacin-Chalcone Hybrid as an Inhibitor of Topoisomerases I & II and Apoptotic Inducer
Doaa Mohamed Elroby Ali, Hossameldin A. Aziz, Stefan Braese, et al.
Molecules (2024) Vol. 29, Iss. 22, pp. 5382-5382
Open Access | Times Cited: 4
Thiazolidine-2,4-dione-linked ciprofloxacin derivatives with broad-spectrum antibacterial, MRSA and topoisomerase inhibitory activities
Hossameldin A. Aziz, Ahmed M. M. El‐Saghier, Mohamed Badr, et al.
Molecular Diversity (2021) Vol. 26, Iss. 3, pp. 1743-1759
Closed Access | Times Cited: 27
Current scenario of chalcone hybrids with antibreast cancer therapeutic applications
Huan Wang, Juanying Zhu, Qianru Zhang, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 5
Closed Access | Times Cited: 3
Advancements in Synthetic Strategies and Biological Effects of Ciprofloxacin Derivatives: A Review
Vuyolwethu Khwaza, Sithenkosi Mlala, Blessing A. Aderibigbe
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4919-4919
Open Access | Times Cited: 3
Design, synthesis and mechanistic study of N-4-Piperazinyl Butyryl Thiazolidinedione derivatives of ciprofloxacin with Anticancer Activity via Topoisomerase I/II inhibition
Hossameldin A. Aziz, Ahmed M. M. El‐Saghier, Mohamed Badr, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Synthesis and molecular docking of new N4-piperazinyl ciprofloxacin hybrids as antimicrobial DNA gyrase inhibitors
Hamada H. H. Mohammed, Doaa Mohamed Elroby Ali, Mohamed Badr, et al.
Molecular Diversity (2022) Vol. 27, Iss. 4, pp. 1751-1765
Open Access | Times Cited: 15
Identification of Anti-Inflammatory and Anti-Proliferative Neolignanamides from Warburgia ugandensis Employing Multi-Target Affinity Ultrafiltration and LC-MS
Xiao-Cui Zhuang, Yongli Zhang, Guilin Chen, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 4, pp. 313-313
Open Access | Times Cited: 14
Ciprofloxacin and Norfloxacin Hybrid Compounds: Potential Anticancer Agents
Sijongesonke Peter, Blessing A. Aderibigbe
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 7, pp. 644-665
Closed Access | Times Cited: 1
Advances in chalcone-based anticancer therapy: mechanisms, preclinical advances, and future perspectives
Shefali Chowdhary, Preeti Preeti, Shekhar Shekhar, et al.
Expert Opinion on Drug Discovery (2024)
Closed Access | Times Cited: 1
An insight into the therapeutic impact of quinoxaline derivatives: Recent advances in biological activities (2020–2024)
Aly M. Waseem, Ranya Mohammed Elmagzoub, Mervat Mohammed Mazhar Abdelgadir, et al.
Results in Chemistry (2024), pp. 101989-101989
Open Access | Times Cited: 1
Design, Synthesis, anticancer evaluation and in silico studies of 2,4,6-trimethoxychalcone derivatives
Tong Li, Weiwei Li, Xianjing Yang, et al.
Saudi Pharmaceutical Journal (2022) Vol. 31, Iss. 1, pp. 65-84
Open Access | Times Cited: 7
Nitrogen‐containing heterocycles as topoisomerase II inhibitors for targeting cancer: Recent updates
Chandrakant Sahu, Abhishek Chaurasiya, Pooja A. Chawla
Journal of Heterocyclic Chemistry (2022) Vol. 60, Iss. 6, pp. 899-928
Closed Access | Times Cited: 5
Insight of Molecular Prevalence on Antibiotic Sensitive <i>H. pylori</i> Biotypes from Apparently Healthy and Clinical Illness Felines and Sheep
Mohamed El Sayed Enany, Hanaa Mohamed Fadel, Usama Hassan Abo-Shama Abdelsadek, et al.
Animal and Veterinary Sciences (2024)
Open Access
New Oxadiazole/ Benzimidazole Hybrids: Design, Synthesis, and Molecular Docking Studies.
Fatma Fouad Hagar, Samar H. Abbas, Ahmed M. Sayed, et al.
Journal of advanced Biomedical and Pharmaceutical Sciences (2023), pp. 97-106
Open Access | Times Cited: 1
Structural Parameters of the Interaction between Ciprofloxacin and Human Topoisomerase-II β Enzyme: Toward New 19F NMR Chemical Shift Probes
Thaís Aparecida Sales, Mateus A. Gonçalves, Teodorico C. Ramalho
Magnetochemistry (2022) Vol. 8, Iss. 12, pp. 181-181
Open Access | Times Cited: 2
Protective effect and mechanism of SeMet-Pro-Ser on K2Cr2O7-induced toxicity in L-02 hepatocytes
Kunlun Liu, Runfeng Du, Yan Zhao
Journal of Functional Foods (2022) Vol. 95, pp. 105148-105148
Open Access
Page 1 - Next Page

Scroll to top